A carregar...
Cost-Utility Analysis of IEV Drug Regimen Versus ESHAP Drug Regimen for the Patients With Relapsed and Refractory Hodgkin and Non-Hodgkin’s Lymphoma in Iran
BACKGROUND: Chemotherapy for lymph nodes cancer is often composed of several drugs that are used in a treatment program. OBJECTIVES: The aim of this study was to perform a cost-utility analysis of IEV regimen (ifosfamide, epirubicin and etoposide) versus ESHAP regimen (etoposide, methylprednisolone,...
Na minha lista:
| Publicado no: | Iran J Cancer Prev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Shahid Beheshti University of Medical Sciences
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4667232/ https://ncbi.nlm.nih.gov/pubmed/26634115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17795/ijcp-4061 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|